UB Paderborn / Katalog / Suche / in CDI

Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis

Clinical and experimental allergy, 2013-05, Vol.43 (5), p.568-577

2013

Volltextzugriff (PDF)

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis

Clinical and experimental allergy, 2009-03, Vol.39 (3), p.387-393

2009

Volltextzugriff (PDF)

Characterization of oral immune cells in birch pollen‐allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen‐presenting cells

Allergy (Copenhagen), 2015-04, Vol.70 (4), p.408-419

2015

Volltextzugriff (PDF)

Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment

Clinical and experimental allergy, 2009-03, Vol.39 (3), p.394-400

2009

Volltextzugriff (PDF)

Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy

Allergy, 2009, Vol.64 (1), p.166-171

2009

Volltextzugriff (PDF)

Safety and tolerability of grass pollen tablets in sublingual immunotherapy – a phase‐1 study

Allergy (Copenhagen), 2006-10, Vol.61 (10), p.1173-1176

2006

Volltextzugriff (PDF)

Comprimé sublingual d’extraits allergéniques d’acariens à 300IR : efficacité dans le traitement des symptômes de rhinite chez les sujets souffrant de rhinite allergique aux acariens dans deux études de Phase III

Revue française d'allergologie (2009), 2017-04, Vol.57 (3), p.282-282

2017

Volltextzugriff (PDF)

Immunological Biomarkers of Grass Allergen Tablets in Grass Pollen Rhinoconjunctivitis Patients

Journal of allergy and clinical immunology, 2008-02, Vol.121 (2), p.S124-S124

2008

Volltextzugriff (PDF)

Effect of cetirizine on bronchial hyperresponsiveness in patients with seasonal allergic rhinitis and asthma

Allergy (Copenhagen), 2001-01, Vol.56 (1), p.35-42

2001

Volltextzugriff (PDF)

Efficacy and Safety of House Dust Mites Allergen Extracts Tablets in Adults With Allergic Rhinitis Patients

Journal of allergy and clinical immunology, 2010-02, Vol.125 (2), p.AB122-AB122

2010

Volltextzugriff (PDF)

Safety and Tolerability of House Dust Mite Tablets in Sublingual Immunotherapy

Journal of allergy and clinical immunology, 2008-02, Vol.121 (2), p.S128-S128

2008

Volltextzugriff (PDF)

Efficacy and Safety of Sublingual Immunotherapy [SLIT] Tablets in Grass Pollen Rhinoconjunctivitis

Journal of allergy and clinical immunology, 2006-03, Vol.117 (3), p.721-721

2006

Volltextzugriff (PDF)

Cartographie des cellules immunitaires dans la muqueuse buccale de patients allergiques au pollen de bouleau présentant ou non un syndrome d’allergie orale avant et après immunothérapie allergénique par voie sublinguale

Revue française d'allergologie (2009), 2014-04, Vol.54 (3), p.249-250

2014

Volltextzugriff (PDF)

Evaluation of pharmacokinetic interaction between cetirizine and ritonavir, an HIV-1 protease inhibitor, in healthy male volunteers

European journal of clinical pharmacology, 2005-06, Vol.61 (4), p.267-273

2005

Volltextzugriff (PDF)

Twenty‐four‐hour activity and consistency of activity of levocetirizine and desloratadine in the skin

British journal of clinical pharmacology, 2003-10, Vol.56 (4), p.388-394

2003

Volltextzugriff (PDF)

Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: The importance of allergen-specific serum IgE

Journal of allergy and clinical immunology, 2012-12, Vol.130 (6), p.1327-1334.e1

2012

Volltextzugriff (PDF)

Intensity of Care, Expenditure, and Place of Death in French Women in the Year Before Their Death From Breast Cancer: A Population-Based Study

Cancer control, 2020, Vol.27 (1), p.1073274820977175-1073274820977175

2020

Volltextzugriff (PDF)

Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen–induced rhinoconjunctivitis

Journal of allergy and clinical immunology, 2011-09, Vol.128 (3), p.559-566

2011

Volltextzugriff (PDF)

Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5–grass pollen tablet for seasonal allergic rhinitis

Journal of allergy and clinical immunology, 2007-12, Vol.120 (6), p.1338-1345

2007

Volltextzugriff (PDF)

Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis

Journal of allergy and clinical immunology, 2008-11, Vol.122 (5), p.951-960

2008

Volltextzugriff (PDF)

Consistency and efficacy of cetirizine (10 mg) versus ebastine (20 mg) at 4 h on skin reactivity

European journal of clinical pharmacology, 1999-10, Vol.55 (8), p.589-592

1999

Volltextzugriff (PDF)

Cétirizine (20 mg/j) versus placebo dans la prévention des réactions secondaires de la désensibilisation accélérée aux venins d'hyménoptères

Revue française d'allergologie et d'immunologie clinique, 1997, Vol.37 (6), p.741-745

1997

Volltextzugriff (PDF)

Sustained Efficacy and Safety Of a Pre-coseasonal 300IR 5-grass Pollen SLIT Tablet Over 3 Pollen Seasons In Adult SAR

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB151-AB151

2011

Volltextzugriff (PDF)

Leukotriene B4 production by blood neutrophils in allergic rhinitis-effects of cetirizine

Clinical and experimental allergy, 1995-08, Vol.25 (8), p.729-736

1995

Volltextzugriff (PDF)

Consistency Of Clinical Results Throughout Short-term And Long-term Studies With Sublingual 300IR 5-grass Pollen Tablets

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB49-AB49

2011

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis

Characterization of oral immune cells in birch pollen‐allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen‐presenting cells

Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment

Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy

Safety and tolerability of grass pollen tablets in sublingual immunotherapy – a phase‐1 study

Comprimé sublingual d’extraits allergéniques d’acariens à 300IR : efficacité dans le traitement des symptômes de rhinite chez les sujets souffrant de rhinite allergique aux acariens dans deux études de Phase III

Immunological Biomarkers of Grass Allergen Tablets in Grass Pollen Rhinoconjunctivitis Patients

Effect of cetirizine on bronchial hyperresponsiveness in patients with seasonal allergic rhinitis and asthma

Efficacy and Safety of House Dust Mites Allergen Extracts Tablets in Adults With Allergic Rhinitis Patients

Safety and Tolerability of House Dust Mite Tablets in Sublingual Immunotherapy

Efficacy and Safety of Sublingual Immunotherapy [SLIT] Tablets in Grass Pollen Rhinoconjunctivitis

Cartographie des cellules immunitaires dans la muqueuse buccale de patients allergiques au pollen de bouleau présentant ou non un syndrome d’allergie orale avant et après immunothérapie allergénique par voie sublinguale

Evaluation of pharmacokinetic interaction between cetirizine and ritonavir, an HIV-1 protease inhibitor, in healthy male volunteers

Twenty‐four‐hour activity and consistency of activity of levocetirizine and desloratadine in the skin

Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: The importance of allergen-specific serum IgE

Intensity of Care, Expenditure, and Place of Death in French Women in the Year Before Their Death From Breast Cancer: A Population-Based Study

Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen–induced rhinoconjunctivitis

Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5–grass pollen tablet for seasonal allergic rhinitis

Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis

Consistency and efficacy of cetirizine (10 mg) versus ebastine (20 mg) at 4 h on skin reactivity

Cétirizine (20 mg/j) versus placebo dans la prévention des réactions secondaires de la désensibilisation accélérée aux venins d'hyménoptères

Sustained Efficacy and Safety Of a Pre-coseasonal 300IR 5-grass Pollen SLIT Tablet Over 3 Pollen Seasons In Adult SAR

Leukotriene B4 production by blood neutrophils in allergic rhinitis-effects of cetirizine

Consistency Of Clinical Results Throughout Short-term And Long-term Studies With Sublingual 300IR 5-grass Pollen Tablets

Suchergebnisse filtern